Cite Filings / BBOT
Feed Companies Filings Check
Sign in

CIK 0001869105

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

BridgeBio Oncology Therapeutics, Inc.

Sign in to watch
Ticker
BBOT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 857-702-0377
Business address
256 E. GRAND AVENUE, SUITE 104, SOUTH SAN FRANCISCO, CA, 94080
Former names
Helix Acquisition Corp. II
Filings Financials Insiders Search text
All 190 Financials 32 Shareholder Meetings 1 Executive Compensation 24 Insider Trading 70 Beneficial Ownership Interest 21 Business Combinations 30 Public Offerings 35 Mutual Funds and ETFs 1 Others 23
›
Filed in
  1. No filings match these filters. Clear filters
  2. 10-Q Report Quarterly Report 2025-08-01
  3. 8-K Event Regulation FD disclosure 2025-07-11
  4. 10-Q Report Quarterly Report 2025-05-15
  5. 10-K Report Annual Report 2025-03-11
  6. 8-K Event ● Material agreement · Unregistered share sale 2025-03-03
  7. 8-K Event Regulation FD disclosure 2025-02-28
  8. 8-K Event ● Executive or director change 2025-02-10
  9. 10-Q Report Quarterly Report 2024-11-14
  10. 10-Q Report Quarterly Report 2024-08-14
  11. 10-Q Report Quarterly Report 2024-05-15
  12. 8-K Event Other events 2024-02-20
  13. 8-K Event ● Material agreement · Unregistered share sale · Executive or director change · Bylaws or fiscal year change · Other events 2024-02-14

Page 2 of 2 · 32 filings

First Previous Next Last

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…